Ronald See to Haloperidol
This is a "connection" page, showing publications Ronald See has written about Haloperidol.
Connection Strength
2.626
-
Convergent evidence from microdialysis and presynaptic immunolabeling for the regulation of gamma-aminobutyric acid release in the globus pallidus following acute clozapine or haloperidol administration in rats. J Neurochem. 2002 Jul; 82(1):172-80.
Score: 0.202
-
Decreased pallidal GABA following reverse microdialysis with clozapine, but not haloperidol. Neuroreport. 2001 Dec 04; 12(17):3655-8.
Score: 0.194
-
Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats. Synapse. 2001 Jan; 39(1):51-7.
Score: 0.182
-
Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats. Neuroscience. 2000; 100(3):507-14.
Score: 0.170
-
Ovariectomy results in lower plasma haloperidol levels in rats following chronic administration. Pharm Res. 1998 Oct; 15(10):1640-2.
Score: 0.156
-
Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation. Pharmacol Biochem Behav. 1998 May; 60(1):167-73.
Score: 0.151
-
Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats. Neuroscience. 1996 May; 72(1):99-104.
Score: 0.132
-
Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats. Brain Res. 1995 Dec 18; 704(2):202-9.
Score: 0.128
-
Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex. Neuroreport. 1995 Sep 11; 6(13):1795-8.
Score: 0.126
-
Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. Eur J Pharmacol. 1994 Oct 03; 263(3):269-76.
Score: 0.118
-
Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia. Neuropsychopharmacology. 1993 Sep; 9(2):101-9.
Score: 0.110
-
Chronic haloperidol does not alter G protein alpha-subunit levels in rats. Brain Res Mol Brain Res. 1993 Aug; 19(3):219-21.
Score: 0.109
-
Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse. 1992 Oct; 12(2):147-54.
Score: 0.103
-
Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats. Neurosci Lett. 1992 Aug 03; 142(1):100-4.
Score: 0.102
-
Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride. Neurosci Lett. 1991 Aug 19; 129(2):265-8.
Score: 0.095
-
Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats. Pharmacol Biochem Behav. 1991 May; 39(1):49-54.
Score: 0.093
-
Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats. Psychopharmacology (Berl). 1990; 100(3):404-12.
Score: 0.085
-
Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors. Life Sci. 1989; 44(3):229-36.
Score: 0.079
-
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. Psychopharmacology (Berl). 1988; 94(3):421-7.
Score: 0.074
-
Recording oral activity in rats reveals a long-lasting subsensitivity to haloperidol as a function of duration of previous haloperidol treatment. Pharmacol Biochem Behav. 1987 Oct; 28(2):175-8.
Score: 0.073
-
Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia. Biol Psychiatry. 1999 Jun 15; 45(12):1653-6.
Score: 0.041
-
Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats. Brain Res. 1992 Aug 14; 588(1):177-80.
Score: 0.025
-
Chronic administration of typical, but not atypical neuroleptics induce persisting alterations in rest-activity cycles in rats. Pharmacol Biochem Behav. 1990 Aug; 36(4):807-11.
Score: 0.022
-
Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur J Pharmacol. 1990 Jun 08; 181(3):175-86.
Score: 0.022
-
Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats. J Neural Transm Gen Sect. 1990; 82(2):93-109.
Score: 0.021
-
Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats. Psychopharmacology (Berl). 1988; 96(2):253-7.
Score: 0.005
-
Neuroleptic-induced oral movements in rats: methodological issues. Life Sci. 1987 Sep 21; 41(12):1499-506.
Score: 0.005
-
Tremorous mouth movements in rats administered chronic neuroleptics. Psychopharmacology (Berl). 1987; 92(1):122-6.
Score: 0.004